Short Interest in Enzolytics, Inc. (OTCMKTS:ENZC) Increases By 115.6%

Enzolytics, Inc. (OTCMKTS:ENZC) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 1,260,500 shares, a growth of 115.6% from the September 30th total of 584,700 shares. Based on an average daily volume of 17,960,300 shares, the short-interest ratio is currently 0.1 days.

Enzolytics Price Performance

Shares of ENZC traded up $0.00 during midday trading on Monday, hitting $0.00. The stock had a trading volume of 9,293,300 shares, compared to its average volume of 10,409,088. Enzolytics has a twelve month low of $0.00 and a twelve month high of $0.03.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.